These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Co-trimoxazole in HIV-1 infection. Badri M; Maartens G; Wood R; Ehrlich R Lancet; 1999 Jul; 354(9175):334-5. PubMed ID: 10440331 [No Abstract] [Full Text] [Related]
9. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Zachariah R; Harries AD; Luo C; Bachman G; Graham SM Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611 [TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries. Zachariah R; Massaquoi M Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438 [TBL] [Abstract][Full Text] [Related]
11. Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ). Nunn AJ; Mwaba PB; Chintu C; Crook AM; Darbyshire JH; Ahmed Y; Zumla AI Trop Med Int Health; 2011 Apr; 16(4):518-26. PubMed ID: 21281407 [TBL] [Abstract][Full Text] [Related]
12. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. ; Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907 [No Abstract] [Full Text] [Related]
13. Considering the benefits of disease-specific interventions on overall public health. Boyd M; Byakwaga H Lancet Infect Dis; 2008 May; 8(5):278. PubMed ID: 18471772 [No Abstract] [Full Text] [Related]
14. Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia. Tumbarello M; Tacconelli E; Cauda R; Ortona L AIDS; 1997 Jul; 11(8):1070-1. PubMed ID: 9223752 [No Abstract] [Full Text] [Related]
15. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham SM Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259 [No Abstract] [Full Text] [Related]
16. Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa. Anglaret X Lancet; 2001 Sep; 358(9287):1027-8. PubMed ID: 11589928 [No Abstract] [Full Text] [Related]
17. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough? Lynen L; Jacobs J; Colebunders R Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321 [TBL] [Abstract][Full Text] [Related]
18. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations. Gaut P; Daar ES Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888 [No Abstract] [Full Text] [Related]
19. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Gill CJ; Sabin LL; Tham J; Hamer DH Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258 [TBL] [Abstract][Full Text] [Related]
20. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection. Anders HJ; Bogner JR; Goebel FD Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]